Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure1

Susan Julie Howard, Daša Cerar, Michael J. M. Anderson, Ahmed Albarrag, Matthew C. Fisher, Alessandro Comarú Pasqualotto, Michél Laverdière, Maiken Cavling Arendrup, David S. Perlin, David W. Denning · 2009

Read Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure1 by Susan Julie Howard, Daša Cerar, Michael J. M. Anderson, Ahmed Albarrag, Matthew C. Fisher, Alessandro Comarú Pasqualotto, Michél Laverdière, Maiken Cavling Arendrup, David S. Perlin, David W. Denning (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w2169748580.txt.

Description

Susan Howard, Daša Cerar, and Michael Anderson led this 2009 study in Emerging Infectious Diseases. They checked how often the mold Aspergillus fumigatus shrugs off azole drugs. Azoles are the main pills used against aspergillosis. Drug failure had been rare, and the team tied it to cases where care failed.

In a Manchester set of over five hundred samples, one in twenty beat itraconazole. That rate had clearly risen since 2004. Most of those samples also beat the other two main azoles. Nearly every patient behind them had taken azoles before. Many of their cases got worse or failed to improve on the drugs. The study marks this as a growing threat in care.

Catalog record

CREATORSusan Julie Howard, Daša Cerar, Michael J. M. Anderson, Ahmed Albarrag, Matthew C. Fisher, Alessandro Comarú Pasqualotto, Michél Laverdière, Maiken Cavling Arendrup, David S. Perlin, David W. Denning
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / Emerging infectious diseases

Source: https://doi.org/10.3201/eid1507.090043

Browse the full library · About the Tower of Babel